Recent Research | Page 72 | Aplastic Anemia and MDS International Foundation

Recent Research

Compiled for your convenience are the latest articles on bone marrow failure research and treatment from the world’s major journals on hematology / oncology. Articles are obtained from the National Library of Medicine’s MEDLINE database and date back to 2010.

Article Titlesort descending Original Publication Date Journal Bone Marrow Disease
The different immunoregulatory functions of mesenchymal stem cells in patients with low-risk or high-risk myelodysplastic syndromes Jan 2012 PLoS One myelodysplastic syndromes (MDS)
The difficulty to define progression patterns in patients with early stage myelodysplastic syndromes and deletion 5q-New prognostic markers are needed Dec 2013 Leuk Res myelodysplastic syndromes (MDS)
The dysfunction of platelets in paroxysmal nocturnal hemoglobinuria Jul 2016 Thromb Res paroxysmal nocturnal hemoglobinuria (PNH)
The Effect of Decitabine Dose Modification and Myelosuppression on Response and Survival in Patients With Myelodysplastic Syndromes May 2014 Leuk Lymphoma myelodysplastic syndromes (MDS)
The Efficacy of Current Prognostic Models in Predicting Outcome of Patients with Myelodysplastic Syndromes at the Time of Hypomethylating Agent Failure Mar 2016 Haematologica myelodysplastic syndromes (MDS)
The Evaluation of iron overload through hepcidin level and its related factors in myelodysplastic syndromes. Mar 2013 Hematology myelodysplastic syndromes (MDS)
The Genetic Basis and Expanding Role of Molecular Analysis in the Diagnosis, Prognosis, and Therapeutic Design for Myelodysplastic Syndromes Jan 2014 J Mol Diagn myelodysplastic syndromes (MDS)
The Hematopoietic Cell Transplantation Comorbidity Index (HCT-CI) Predicts Outcomes in Patients with Acute Myeloid Leukemia and Myelodysplastic Syndromes Receiving CD34+ Selected Grafts for Allogeneic Hematopoietic Cell Transplantation Oct 2016 Biol Blood Marrow Transplant myelodysplastic syndromes (MDS)
The immune landscape of myelodysplastic syndromes Nov 2016 Crit Rev Oncol Hematol myelodysplastic syndromes (MDS)
The immunomodulatory agents lenalidomide and thalidomide for treatment of the myelodysplastic syndromes: A clinical practice guideline. Aug 2012 Crit Rev Oncol Hematol aplastic anemia